2,539
Views
9
CrossRef citations to date
0
Altmetric
Editorials

HIV immunotherapy comes of age: implications for prevention, treatment and cure

, &
Pages 91-94 | Received 10 Aug 2015, Accepted 21 Oct 2015, Published online: 02 Dec 2015

References

  • Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–271. DOI:10.1016/S0140-6736(14)60164-1.
  • Rajasuriar R, Wright E, Lewin SR. Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage. Curr Opin HIV AIDS. 2015;10(1):35–42. DOI:10.1097/COH.0000000000000118.
  • Burton DR, Mascola JR. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol. 2015;16(6):571–576. DOI:10.1038/ni.3158.
  • Alter G, Sekaly RP. Beyond adjuvants: antagonizing inflammation to enhance vaccine immunity. Vaccine. 2015;33(Suppl 2):B55–9. DOI:10.1016/j.vaccine.2015.03.058.
  • Burgener A, Sainsbury J, Plummer FA, et al. Systems biology-based approaches to understand HIV-exposed uninfected women. Curr HIV/AIDS Rep. 2010;7(2):53–59. DOI:10.1007/s11904-010-0039-3.
  • Parsons MS, Boulet S, Song R, et al. Mind the gap: lack of association between KIR3DL1*004/HLA-Bw4-induced natural killer cell function and protection from HIV infection. J Infect Dis. 2010;202(Suppl 3):S356–60. DOI:10.1086/655966.
  • Jardine J, Julien JP, Menis S, et al. Rational HIV immunogen design to target specific germline B cell receptors. Science. 2013;340(6133):711–716. DOI:10.1126/science.1234150.
  • Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209–2220. DOI:10.1056/NEJMoa0908492.
  • Williams WB, Liao HX, Moody MA, et al. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science. 2015. DOI:10.1126/science.aab1253.
  • Balazs AB, Chen J, Hong CM, et al. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature. 2012;481(7379):81–84. DOI:10.1038/nature10660.
  • Hansen SG, Piatak M Jr., Ventura AB, et al. Immune clearance of highly pathogenic SIV infection. Nature. 2013;502(7469):100–104. DOI:10.1038/nature12519.
  • Dagenais-Lussier X, Mouna A, Routy JP, et al. Current topics in HIV-1 pathogenesis: the emergence of deregulated immuno-metabolism in HIV-infected subjects. Cytokine Growth Factor Rev. 2015. DOI:10.1016/j.cytogfr.2015.09.001.
  • Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog. 2013;9(3):e1003211. DOI:10.1371/journal.ppat.1003211.
  • Archin NM, Liberty AL, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487(7408):482–485. DOI:10.1038/nature11286.
  • Garcia F, Routy JP. Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection workshop in dendritic cell-based vaccine clinical trials in HIV-1. Vaccine. 2011;29(38):6454–6463. DOI:10.1016/j.vaccine.2011.07.043.
  • Andres C, Plana M, Guardo AC, et al. HIV-1 reservoir dynamics after vaccination and antiretroviral therapy interruption are associated with dendritic cell-vaccine induced T-cell responses. J Virol. 2015. DOI:10.1128/JVI.01062-15.
  • Caskey M, Klein F, Lorenzi JC, et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature. 2015;522(7557):487–491. DOI:10.1038/nature14411.
  • Cao W, Mehraj V, Vyboh K, et al. Antiretroviral therapy in primary HIV-1 infection: influences on immune activation and gut mucosal barrier dysfunction. AIDS Rev. 2015;17(3):135–146.
  • Zitvogel L, Galluzzi L, Kepp O, et al. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15(7):405–414. DOI:10.1038/nri3845.
  • International ASSWGoHIVC, Deeks SG, Autran B, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12(8):607–614. DOI:10.1038/nri3262.
  • Sereti I, Estes JD, Thompson WL, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10(1):e1003890. DOI:10.1371/journal.ppat.1003890.
  • Ortiz AM, Klase ZA, DiNapoli SR, et al IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol. 2015. DOI:10.1038/mi.2015.75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.